Top Markets
Coin of the day
Hualan Biological Engineering Inc. Hualan Biological Engineering Inc.

Hualan Biological Engineering Inc.

002007
Rank in Stocks #4590
Hualan Biological Engineering Inc. operates as a biopharmaceutical company,... Hualan Biological Engineering Inc. operates as a biopharmaceutical company, specializing in the research, development, production, and commercialization of a diverse portfolio of medical products within the People's Republic of China. Its offerings span plasma-derived therapies, various viral and bacterial vaccines, recombinant proteins, and other advanced biologics. The company's extensive range of plasma products includes essential components like human albumin, a broad spectrum of human immunoglobulins (such as intravenous, rabies, hepatitis B, and tetanus formulations), and vital coagulation factors like human prothrombin complex and factor VIII. Hualan also provides specialized solutions such as lyophilized human thrombin for external use and surgical fibrin glue. In its vaccine division, Hualan offers critical immunizations, including several influenza vaccines (e.g., split virus, A H1N1, and quadrivalent forms), recombinant hepatitis B vaccine, and ACYW135 meningococcal polysaccharide vaccine. The company actively pursues strategic collaborations with key scientific organizations, most notably the Chinese Academy of Sciences, as well as other esteemed research institutes and enterprises. Established in 1992, Hualan Biological Engineering Inc. is headquartered in Xinxiang, People's Republic of China.
Share Price
$1.92
Market Cap
$3.51B
Change (1 day)
1.07%
Change (1 year)
-22.38%
Country
CN
Trade Hualan Biological Engineering Inc. (002007)

Category

Stock price history for Hualan Biological Engineering Inc. (002007)
Highest end of day price: $1.92 on 2026-08-01

Lowest end of day price: $0.04 on 2005-07-01
Stock price history of Hualan Biological Engineering Inc. from 2005 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -1.48%
2025 -8.00%
2024 -26.26%
2023 5.17%
2022 -32.17%
2021 -32.50%
2020 81.00%
2019 39.14%
2018 22.13%
2017 -17.00%
2016 25.76%
2015 14.39%
2014 25.00%
2013 43.76%
2012 -19.64%
2011 -47.09%
2010 42.91%
2009 145.21%
2008 -12.56%
2007 226.27%
2006 338.48%
2005 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$549.38 41.89%
US
$1.05K 47.72%
NL
$148.35 499.86%
US
$121.62 -12.98%
AU
$764.47 6.25%
CH